Results

Total Results: 10 records

Showing results for "death".

  1. cds.ahrq.gov/taxonomy/term/22536
    April 04, 2018 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  2. cds.ahrq.gov/taxonomy/term/57436
    February 26, 2019 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  3. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation_Guide_CMS_Million_Hearts_ASCVD_Risk_Assessment.pdf
    September 01, 2021 - “hard” ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … hard“ ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … hard” ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … risk” Risk of showing evidence of ASCVD within the next 10 years ACC/AHA “hard” Nonfatal MI, CHD death
  4. cds.ahrq.gov/sites/default/files/cds/artifact/71/Implementation%20Guide_CMS%20Million%20Hearts_ASCVD%20Risk%20Assessment_Level3_Final.pdf
    February 01, 2018 - “hard” ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … "hard" ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … "hard" ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death … risk" Risk of showing evidence of ASCVD within the next 10 years ACC/AHA "hard" Nonfatal MI, CHD death
  5. cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Pitavastatin 2-4 mg Grade B "for the prevention of" to maintain health in order to avert disease and death … Grade B "mortality" death Grade B and C "when all of the following criteria are met" all 3 of
  6. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - antimicrobials for PEP to a patient because of the potential severity of inhalation anthrax, which includes death … potential severity of anthrax disease and adheres to PEP to prevent a negative outcome, including death
  7. cds.ahrq.gov/sites/default/files/cds/artifact/76/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making_Final_0.docx
    October 01, 2017 - first-time “hard” ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death
  8. cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
    April 01, 2021 - “hard” ASCVD event, defined as: nonfatal myocardial infarction (MI), coronary heart disease (CHD) death
  9. cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
    January 01, 2010 - first-time “hard” ASCVD event, defined as nonfatal myocardial infarction (MI), coronary heart disease (CHD) death
  10. cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - Each synthetic patient in the population independently progresses from birth to the current date (or death

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: